Search

Coloplast A-S (Class B)

Gesloten

637.4 -0.22

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

628

Max

641

Belangrijke statistieken

By Trading Economics

Inkomsten

-270M

1B

Verkoop

73M

7B

K/W

Sectorgemiddelde

32.148

54.379

EPS

6.38

Dividendrendement

3.15

Winstmarge

14.859

Werknemers

16,628

EBITDA

-42M

2.2B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+11.86% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.15%

2.55%

Volgende dividenddatum

21 mei 2025

Volgende Ex Dividend datum

19 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

157B

Vorige openingsprijs

637.62

Vorige sluitingsprijs

637.4

Coloplast A-S (Class B) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 mei 2025, 23:48 UTC

Winsten
Acquisities, Fusies, Overnames

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 mei 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 mei 2025, 23:45 UTC

Marktinformatie

Oil Rises Amid Improved Market Mood -- Market Talk

11 mei 2025, 23:38 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 mei 2025, 23:36 UTC

Marktinformatie

Global Markets Uncertain About US-China Trade News -- Market Talk

11 mei 2025, 23:35 UTC

Marktinformatie

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 mei 2025, 23:33 UTC

Winsten
Acquisities, Fusies, Overnames

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 mei 2025, 23:32 UTC

Top Nieuws

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 mei 2025, 22:44 UTC

Marktinformatie

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 mei 2025, 22:33 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 mei 2025, 20:19 UTC

Top Nieuws

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 mei 2025, 16:00 UTC

Top Nieuws

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 mei 2025, 11:00 UTC

Top Nieuws

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 mei 2025, 08:00 UTC

Top Nieuws

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 mei 2025, 01:00 UTC

Top Nieuws

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 mei 2025, 01:00 UTC

Top Nieuws

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 mei 2025, 21:54 UTC

Top Nieuws

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 mei 2025, 17:12 UTC

Top Nieuws

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 mei 2025, 15:41 UTC

Top Nieuws

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 mei 2025, 12:00 UTC

Top Nieuws

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 mei 2025, 09:30 UTC

Top Nieuws

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 mei 2025, 08:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

10 mei 2025, 03:52 UTC

Top Nieuws

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 mei 2025, 23:51 UTC

Acquisities, Fusies, Overnames

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 mei 2025, 22:06 UTC

Marktinformatie

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 mei 2025, 21:37 UTC

Top Nieuws

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 mei 2025, 21:10 UTC

Top Nieuws

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 mei 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

9 mei 2025, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

9 mei 2025, 20:42 UTC

Top Nieuws

Stocks Get a Break From Trade Chaos -- WSJ

Coloplast A-S (Class B) Prognose

Koersdoel

By TipRanks

11.86% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 901.38 DKK  11.86%

Hoogste 1,056 DKK

Laagste 720 DKK

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Coloplast A-S (Class B) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

2

Buy

4

Hold

2

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.